Titles
- Rebalancing in capitated Medicaid managed long-term services and supports programs: key issues from a roundtable discussion on measuring performance1
- Rebalancing long-term care: the role of the Medicaid HCBS waiver program1
- Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 20151
- Recent Medicaid/CHIP enrollment declines and barriers to maintaining coverage1
- Recent growth in health expenditures1
- Recent trends in Medicaid and CHIP enrollment as of January 2015: early findings from the CMS Performance Indicator Project1
- Recipe for in-clinic nutrition education1
- Reclaiming futures, rebuilding lives1
- Reclassifying health insurance coverage for the Indian Health Service in the current population survey: impact on state uninsurance estimates1
- Recognition and withdrawal of voluntary consensus standards: guidance for industry and Food and Drug Administration staff1
- Recognizing destabilization in the individual health insurance market1
- Recommendation followup: vulnerabilities continue to exist in the HHS small business innovation research program1
- Recommendations for clinical laboratory improvement amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices: guidance for industry and Food and Drug Administration staff1
- Recommendations for dual 510(k) and CLIA waiver by application studies: guidance for industry and Food and Drug Administration staff1
- Recommendations for evaluating donor eligibility using individual risk-based questions to reduce the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry1
- Recommendations for programs and funders who serve people who use substances: disrupting structural racism’s impact on health and well-being1
- Recommendations for reducing the risk of transfusion-transmitted babesiosis1
- Recommendations to improve access to mental health services for children with special health care needs in California1
- Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components2
- Recommendations to reduce the risk of transfusion-transmitted malaria: guidance for industry1